INTRODUCTION
Intrauterine growth restriction is a significant contributor to perinatal mortality and morbidity and remains a major obstetric and neonatal challenge. 1 Placental-bed biopsy studies indicate that a failure of the placenta to create an adequate uteroplacental circulation is the major underlying factor in the pathogenesis of fetal growth restriction. 2, 3 The best treatment we can offer a fetus with growth restriction due to uteroplacental insufficiency whose circulation and homeostasis are progressively deteriorating is extraction at the most appropriate moment. So the most critical decision for such pregnancies is the appropriate timing of delivery, which is often difficult to judge.
Absent or reversed end-diastolic flow velocity (AEDFV) waveforms in the umbilical arteries of growth-restricted fetuses have been presented by many investigators as a sign of poor fetal outcome. 4, 5 The prevalence of perinatal death in this group is reported to be over 40% and fetal blood obtained by funicentesis frequently demonstrates evidence of chronic hypoxia. 6, 7 Therefore, many investigators have suggested that perinatal management of these pregnancies should be aggressive and AEDFV detected in the umbilical artery of a growthrestricted fetus is an indication for delivery. 8, 9 However, decision of delivery is not always that easy. AEDFV in the umbilical artery is mostly present before a gestational age of 34 weeks. 10 In some cases, depending on the decision of delivery, a fetal death may translate into a neonatal loss. This finding in the preterm fetus presents a clinical dilemma in the management (i.e., conservative vs. delivery). Therefore, it will be of great importance to find out the prognostic factors for survival for pregnancies with AEDFV in the umbilical artery.
The aim of this study is to evaluate the clinical characteristics and the prognostic factors for survival of growth-restricted fetuses with AEDFV in the umbilical artery.
MATERIAL AND METHODS
The study group consisted of 45 intrauterine growth-restricted fetuses with either absent end-diastolic velocity (34 fetuses) or reverse flow (11 fetuses) in the umbilical arteries. Fetuses with chromosomal or structural abnormalities were excluded from the study. Pregnancies were precisely dated based on reliable menstrual dates or early ultrasonography. Intrauterine growth restriction was diagnosed when fetal abdominal circumference was more than 2 SD below the mean for gestational age and was confirmed by the serial assessment of the fetal growth parameters. 11 All of the pregnancies had oligohydramnios and 53.5% of them were preeclamptic. The diagnosis of preeclampsia was established in accordance with the
OBJECTIVE:
The aim of the study was to evaluate the prognostic factors for survival of growth -restricted fetuses with absent end -diastolic velocity in the umbilical artery.
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The mean gestational age at birth and birth weight were 30.8 ± 2.4 weeks and 972 ± 337 g, respectively. The perinatal mortality was 40%. Gestational age at birth was found to have the only significant contribution to the prediction of perinatal deaths. Fetuses with a gestational age at delivery less than 29 weeks died and more than 31 weeks survived. Thoracic artery pulsatility index had the best screening efficiency for predicting perinatal mortality between 29 and 31 weeks gestational age.
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definitions of the American College of Obstetricians and Gynecologists (ACOG).
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After informed verbal consent was obtained, Doppler recordings were performed using an Ultramark 9 (Advanced Technologies Laboratory, Bothell, WA) with a 3.5-Mhz curved linear-array transducer. The high-pass filter was set at 100 Hz. All measurements were performed with the mothers in a semirecumbent position and when there were no fetal gross body or chest movements. Umbilical artery velocity waveforms were recorded by means of previously reported technique. 13 The diagnosis of AEDFV was confirmed by Doppler sampling obtained at three different sites. AEDFV was defined when shifts in frequency at the end of diastole were absent and reverse flow when there were detectable reverse velocity flow during diastole. Following the diagnosis of AEDFV in the umbilical artery, recordings were made from the middle cerebral artery and thoracic aorta as previously described. 13 We attempted to achieve an angle close to 0 degrees between the Doppler ultrasound beam and the direction of blood flow in each vessel. The pulsatility index (PI) [(maximum velocityÀminimum velocity)/mean velocity] was calculated and the mean of five consecutive cardiac cycles was taken for each group of waveform. Detected PI values were defined as normal, high, or low for that gestational age according to referred specific charts for each vessel.
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Fetal heart rate monitoring was recorded for 60 min at the same time as the Doppler studies, using a Hewlett-Packard 8040 cardiotochograph (Hewlett-Packard, Boblingen, Germany). The Sonicaid System 8000 (Sonicaid, Oxford, UK) was used for online computer analysis of the 60-min fetal heart rate tracings. Tracings were identified as reactive, nonreactive, and decelerative by the system and also verified by visual analysis. The shortterm variability calculated by the computer was used for analysis.
Delivery decision for each pregnant woman was made individually, taking into account the maternal condition (severe preeclamptic patients were delivered for maternal reason), gestational age of the fetus, cardiotocography, and Doppler findings as a whole. The families were counseled regarding the chances of survival based on survival rates in our hospital and they were involved in decision making, particularly when a decision of not to deliver was made. The time interval between the time of diagnosis and intrauterine death was determined for each of these stillbirths.
All of the liveborn deliveries were performed by cesarean section. The umbilical cord was clamped within 5 seconds after delivery, and blood samples were drawn anaerobically into heparinized polyethylene syringes and analyzed in an automatic blood gas analyzer (ABL-3 radiometer, Kopenhag, Denmark) within 10 minutes after delivery.
One-way ANOVA and Pearson chi-square tests were used to compare the mean values and the frequency of outcomes between the fetuses that died and survived. Logistic regression analysis was performed to determine the contribution of the various independent variables in the prediction of perinatal deaths. Receiver operator characteristic curves were used to determine the 
RESULTS
The clinical characteristics of the study group are given in Table 1 . Gestational age at delivery was equal to or less than 30, 32, and 34 weeks in 51.1%, 73.3%, and 91.1% of the cases, respectively. Birth weight was equal to or less than 1000 and 1500 g in 66.7% and 95.6% of the cases, respectively. There were only four fetuses born greater than 34 weeks of gestation and two fetuses with birth weight more than 1500 g. The mean umbilical vein pH at birth of the liveborn fetuses was 7.17±0.11 with a range of 6.91 to 7.29. All of the liveborn fetuses had pH values 2 SD below the mean for gestational age.
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There were 18 perinatal deaths due to fetal asphyxia. Of these deaths, 10 were stillbirths and the remaining 8 were early neonatal deaths. The time interval between detection of AEDFV in the umbilical artery and antepartum death ranged between 3 and 18 days with a median of 7 days. Perinatal mortality of the growth-restricted and appropriate for gestational age fetuses taken as a control group, according to the gestational age at birth and birth weight, is shown in Table 2 . The perinatal deaths of growth-restricted fetuses were all less than 32 weeks of gestation and birth weights were less than 1000 g. The clinical characteristics of the growth-restricted fetuses that died and survived are illustrated in Table 3 .
Cardiotochography tracings were found to be reactive, nonreactive, and decelerative in 6 (13.3%), 27 (60%) and 12 (26.7%) of the fetuses, respectively. The mean short-term variability of the 45 fetuses were 3.53±1.47 cycles. There were no significant differences between the short-term variability of the fetuses that died and survived (3.1±1.1 vs. 3.7±1.6, p=0.298). Of the fetuses with reactive, nonreactive, and decelerative tracings 1 (16.7%), 13 (48.1%), and 4 (33.3%) died, respectively ( 2 =2.33, p=0.312). The fetus with a reactive tracing that died in the early neonatal period due to perinatal asphyxia was delivered at 29 weeks' gestation for maternal condition (severe preeclampsia). Of the fetuses with reverse flow in the umbilical artery, absent end diastolic flow in both the umbilical artery and the thoracic aorta and absent end diastolic flow only in the umbilical artery 5 (45.5%), 10 (50%), and 3 (21.4%) died, respectively ( 2 =2.98, p=0.225). To determine the relative value of gestational age at birth, umbilical artery, thoracic artery, and middle cerebral artery Doppler velocimetry and short-term variability determined by cardiotochography in the prediction of perinatal mortality, we conducted logistic regression analysis (Table 4) . Gestational age at birth was found to have the only significant contribution to the prediction of perinatal deaths. As all of the fetuses with a gestational age at delivery less than 29 weeks died and more than 31 weeks survived, we specifically evaluated the mentioned period. There were 24 fetuses (53.3% of the cases) of which 11 died (11/24, 45.8%) with a gestational age at birth between 29 and 31 weeks. Figure 1 shows the receiver operator characteristic curves of umbilical artery, thoracic artery and middle cerebral artery PI values for the prediction of perinatal mortality. Thoracic artery PI value of 2.90 is found to have the best screening efficiency with 82% sensitivity and 47% specificity for predicting perinatal mortality for the cases delivered between 29 and 31 weeks' gestation.
DISCUSSION
Inadequate uteroplacental perfusion leads to fetal hypoxemia, which triggers the fetal defense mechanisms designed to limit the extent of Figure 1 . Receiver operator characteristic curves of umbilical artery, thoracic artery, and middle cerebral artery PI values for the prediction of perinatal mortality (24 fetuses with gestational age at birth between 29 and 31 weeks ). MCAPI = middle cerebral artery pulsatility index; UAPI = umbilical artery pulsatility index; AOPI = thoracic artery pulsatility index.
Madazli Absent End-Diastolic Velocity in the Umbilical Artery asphyxia and to avoid fetal death. A healthy fetus is equipped with a significant number of mechanisms and strategies for reducing the impact of asphyxia. Severe and possibly irreversible damage occurs only when the impact of anoxia exceeds the capacity of defense mechanisms. The goal of any antenatal fetal surveillance method is to detect the disease state of the fetus and prevent perinatal mortality.
The main objective of any clinician should be the detection of fetuses that are at risk of developing severe acidemia before they become acidotic.
The umbilical arteries reflect maldevelopment of the placental tertiary stera villous tree, the principal site of respiratory gas exchange. 14, 15 The magnitude of histologic changes correlates with abnormal umbilical artery Doppler velocimetry, being severe in cases of AEDFV. 16 Absent end-diastolic velocity in the umbilical artery is mostly present in severe growth-restricted fetuses before 32 to 34 weeks' gestation, being a very rare finding after 36 weeks' gestation. 10 In our study group, 73% and 91% of the cases are also found to be less than 32 and 34 weeks' gestation, respectively. If there is a developmental problem of the villi, so severe to form AEDFV in the umbilical artery, it is not surprising to detect it clinically before 34 weeks' gestation. Thus, AEDFV detected in the umbilical artery is mainly a problem of severe preterm growthrestricted fetuses.
The finding of AEDFV in the umbilical artery is associated with high perinatal mortality. 4 We also observed a perinatal mortality of 40%. Fetuses with AEDFV in the umbilical artery, if not delivered, died in utero within 3 weeks (median 7 days). Furthermore, all of the liveborn fetuses were acidemic, with pH values 2 SD below the mean for gestational age. Therefore, we believe, like many others, that AEDFV detected in the umbilical artery of a growth-restricted fetus is an indication for delivery. However, for some fetuses delivery decision may only translate a fetal death into a neonatal loss -hence the mode of death in these circumstances depends on the action or inaction of the obstetrician.
Our data suggest that gestational age at birth is the major contributor to the perinatal deaths. All of the fetuses with a gestational age at delivery less than 29 weeks died and more than 31 weeks survived. This close connection between gestational age at birth and survival may be more than a straightforward gestational age-survival relation. Fetuses with the same pathologic finding as AEDFV in the umbilical artery at different gestational ages will probably have different placental histologies and functional capacities. Fetuses with more severe placental pathology will have an early detection of AEDFV in the umbilical artery and less chance of survival. At least for our unit, severe preterm and growth-restricted fetuses (less than 28 weeks' gestation and estimated fetal weight less than 800 g) with AEDFV in the umbilical artery are found to have no chance of survival. Therefore, gestational age and chance of survival of such fetuses should be taken into consideration in decision making and counseling with the parents.
Gestational ages at birth between 29 and 31 weeks were the critical period for survival in our group. More than half of the fetuses (53.3%) were born between these gestational weeks and almost half of them (45.8%) died (antenatal or neonatal). In this specified time period, thoracic artery Doppler investigation is found to have the best prognostic efficiency for survival. Increased impedance in the thoracic artery is a sign of redistribution of fetal blood. Thoracic artery PI values above 2 SD for gestational age is found to have 82% sensitivity and 47% specificity for predicting perinatal mortality. The absence of end-diastolic frequencies in the aortic flow velocity waveforms is a sign of severe redistribution of the fetal blood, associated with high incidence of perinatal mortality and morbidity. 17 Our data also confirm that growthrestricted fetuses with AEDFV detected both in the umbilical artery and thoracic aorta are severely compromised, and time gained in utero has no benefit for the fetus. Timing of delivery of fetuses with AEDFV in the umbilical artery depends on gestational age, and good clinical judgment with individualization is needed. Both maternal and fetal risk-benefit assessments must be taken into consideration.
